Intuitive warns of escalating tariff impact through 2025, despite strong Q1
CEO Gary Guthart quelled concerns of reflexive pricing, with production and manufacturing optimisation a priority instead.
Robotics
Da Vinci and Hugo among 11 robotic systems recommended for NHS use
Why 2025 is a key year for the surgical robotics market
JP Morgan 2025: Intuitive Surgical continues to battle GLP-1RA pressures
Capstan Medical secures $110m for robotic-assisted heart valve implants
EndoQuest wins FDA IDE to commence robot trial in colorectal indication
Successful NaoTrac-assisted procedures mark first for Bolivian neurosurgery
J&J MedTech wins IDE for Ottava to greenlight trials for surgical robot
